Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion+ non-small-cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Drilon, A. E.; Gautschi, O.; Besse, B.; Subbiah, V.; Tan, D. S. W.; Park, K.; De Braud, F. G.; Alonso, G.; Wolf, J.; Soldatenkova, V.; French, P. P.; Lin, A. K.; Goto, K.; Solomon, B. J. |
| Abstract Title: | Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion+ non-small-cell lung cancer (NSCLC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120605013 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.9032 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9032 -- Source: Wos |
